Development of an Oncolytic Herpes Simplex Virus Using a Tumor-Specific HIF-responsive Promoter
Cancer Gene Therapy - United Kingdom
doi 10.1038/cgt.2010.62
Full Text
Open PDFAbstract
Available in full text
Date
October 8, 2010
Authors
Publisher
Springer Science and Business Media LLC